In contrast, another genome‐wide association study focused only on the northern European ancestry in Sweden and identified an association between the AOX1 locus and prostate cancer‐specific survival.10 Therefore, the strengths of our study include a well‐characterized Taiwanese patient cohort from a defined geographical region, with complete medical information and significant follow‐up times, as well as a comprehensive coverage of common genetic variants across all genes of the anoctamin family. This evidence concerns the gene AOX1 and prostate cancer.